Zrinka Ivezic‐Schoenfeld

Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections

William Prince, Zrinka Ivezic‐Schoenfeld, Claudia P. Lell et al. · Antimicrobial Agents and Chemotherapy · 2013 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)

Hélio S. Sader, Susanne Paukner, Zrinka Ivezic‐Schoenfeld et al. · Journal of Antimicrobial Chemotherapy · 2012 · 87 citations

Life Sciences, Infectious Diseases, Microbiology +17

Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010

Susanne Paukner, Hélio S. Sader, Zrinka Ivezic‐Schoenfeld et al. · Antimicrobial Agents and Chemotherapy · 2013 · 84 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections

Hélio S. Sader, Douglas J. Biedenbach, Susanne Paukner et al. · Antimicrobial Agents and Chemotherapy · 2012 · 82 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Synthesis and biological activity of 4″-O-acyl derivatives of 14- and 15-membered macrolides linked to ω-quinolone-carboxylic unit

Maja Matanović Škugor, Vlado Štimac, Ivana Palej et al. · Bioorganic & Medicinal Chemistry · 2010 · 42 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17